Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
J Neurosurg
; 136(1): 56-66, 2022 Jan 01.
Article
in En
| MEDLINE
| ID: mdl-34087798
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Neurosurg
Year:
2022
Document type:
Article